65 related articles for article (PubMed ID: 2921130)
1. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma.
Luo RX; Tang QX; Huang YW; Liao YP; Mou XD; Hu ZX
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):307-10. PubMed ID: 2921130
[TBL] [Abstract][Full Text] [Related]
2. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma--an analysis of 1446 cases with squamous cell carcinoma grade 3.
Luo RX; Tang QX; Guo KP; Huang YW; Hu ZX
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1107-9. PubMed ID: 7961018
[TBL] [Abstract][Full Text] [Related]
3. [Late course conformal radiotherapy combined with chemotherapy for stage III and IV a nasopharyngeal carcinoma].
Wu H; Lin Q; Yu ZH; Yang ZX; Feng LP
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1778-80. PubMed ID: 16253169
[TBL] [Abstract][Full Text] [Related]
4. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma.
Daoud J; Toumi N; Siala W; Ghorbel A; Drira MM; Frikha M
Radiother Oncol; 2007 Oct; 85(1):17-23. PubMed ID: 17343938
[TBL] [Abstract][Full Text] [Related]
5. Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC).
Chen WZ; Zhou DL; Luo KS
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):311-4. PubMed ID: 2921131
[TBL] [Abstract][Full Text] [Related]
6. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
7. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
8. [Radiotherapy of nasopharyngeal carcinoma].
Oguchi M; Kiyono K; Watanabe T; Sone S; Imai Y; Kawai T; Takei K; Maruyama K; Maruyama Y
Gan No Rinsho; 1987 Oct; 33(12):1407-13. PubMed ID: 3682192
[TBL] [Abstract][Full Text] [Related]
9. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
10. Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results.
Lee RE; Carr DT; Childs DS
AJR Am J Roentgenol; 1976 Jan; 126(1):116-22. PubMed ID: 175669
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy of squamous cell lung cancer].
Nakama M; Sugawara T; Nakashima N; Tamura K
Gan No Rinsho; 1988 Nov; 34(14):1927-35. PubMed ID: 3204662
[TBL] [Abstract][Full Text] [Related]
13. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
14. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].
Cao KJ; Li Y; Xie GF; Hong MH
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):134-7. PubMed ID: 16750020
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
17. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
19. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
